EspressoLogy

Blue Jet Healthcare Limited is coming out with a fresh public issue to raise Rs. 840.27 crores from the market.

Below are the details of the Blue Jet Healthcare Limited IPO:

• Issue opens – October 25 (Wednesday)
• Issue closes – October 27 (Friday)
• Issue size – Rs. 840.27 crores
• Price band – Rs. 329 to Rs. 346 per equity share
• Bid lot – 43 shares and in multiples thereof.

Heard about Pre-Apply IPO?

With Espresso’s Pre-Apply IPO feature, you can apply for IPOs before the start date or even after the market hours! Check out these easy-to-follow tutorials:

And here are some details of the company and further details on the Blue Jet Healthcare Limited IPO.

Company details:

• Blue Jet Healthcare Limited incorporated in 1968 is a specialty pharmaceutical and healthcare ingredients and intermediates company, offering niche products targeted toward innovator pharmaceutical companies and multi-national generic pharmaceutical companies. They have established a contract development and manufacturing organization (“CDMO”) business model with specialized chemistry capabilities in contrast media intermediates and highintensity sweeteners, on the back of strategic and early investments in research and development (“R&D”) and manufacturing infrastructure. They have competencies and manufacturing capabilities in contrast media intermediates and high-intensity sweeteners, including saccharin and its salts. They manufacture a range of products in-house, including the key starting intermediate and advanced intermediates, which allows them to control their production process for consistent quality and cost effectiveness.
• Their operations are primarily organized in three product categories: (i) contrast media intermediates, (ii) highintensity sweeteners, and (iii) pharma intermediates and active pharmaceutical ingredients (“APIs”).
• In the past three Financial Years and the three months ended June 30, 2023, they invoiced a total of more than 400 customers in 39 countries. They have built a long-term customer base with innovator pharmaceutical companies and multi-national generic pharmaceutical companies, supported by committed multi-year contracts of up to five years. They believe their “Collaboration, Development, Manufacturing” approach has been, and will continue to be critical to their success and a key factor for growing their CDMO business. Their product capabilities across the pharmaceutical and healthcare categories have evolved with their customers’ needs, supported by their manufacturing capabilities and technology-driven product development.
• They derive a majority of their revenue from sales of products across their product categories from the regulated markets of Europe. They currently operate three manufacturing facilities, which are located in Shahad (Unit I), Ambernath (Unit II) and Mahad (Unit III) in the state of Maharashtra.

Issue Size:

Rs. 840.27 crores

Issue break-up:

• QIB – 50% of the offer – Rs. 420.13 crores
• NIB – 15% of the offer – Rs. 126.04 crores
• RET – 35% of the offer – Rs. 294.09 crores

Listing:

BSE and NSE

Registrar:

Link Intime India Private Limited

UPI:

All Retail & NII bidders' (bids up to Rs. 5,00,000) applications through brokers are compulsorily in UPI Mode.

Note:

• Application made using third party UPI or ASBA Bank A/c are liable to be rejected. 
• The UPI Mandate acceptance time for Retail and NII Bidders (bids up to Rs. 5,00,000) shall expire at 5:00 PM on the closing day of the IPO i.e. Friday, October 27, 2023     

Not an Espresso customer, but still want to apply for the Blue Jet Healthcare Limited IPO? Become an Espresso customer in just 15 mins* by tapping here and take it from there! (* T&C apply)